These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32122906)

  • 1. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.
    Jacoby P; Glover C; Damon C; Fathima P; Pillsbury A; Durrheim D; Gold MS; Leeb A; Snelling T
    BMJ Open; 2020 Mar; 10(2):e031851. PubMed ID: 32122906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.
    Pillsbury A; Cashman P; Leeb A; Regan A; Westphal D; Snelling T; Blyth C; Crawford N; Wood N; Macartney K;
    Euro Surveill; 2015; 20(43):. PubMed ID: 26536867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.
    Pillsbury AJ; Glover C; Jacoby P; Quinn HE; Fathima P; Cashman P; Leeb A; Blyth CC; Gold MS; Snelling T; Macartney KK
    BMJ Open; 2018 Oct; 8(10):e023263. PubMed ID: 30341132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C; Crawford N; Leeb A; Wood N; Macartney K
    Vaccine; 2020 Jun; 38(31):4892-4900. PubMed ID: 32499067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-vaccination healthcare attendance rate as a proxy measure for syndromic surveillance of adverse events following immunisation.
    Mesfin YM; Cheng AC; Enticott J; Lawrie J; Buttery J
    Aust N Z J Public Health; 2021 Apr; 45(2):101-107. PubMed ID: 33617131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.
    Petousis-Harris H; Poole T; Turner N; Reynolds G
    Vaccine; 2012 Jul; 30(33):4945-52. PubMed ID: 22664224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.
    Dey A; Gidding HF; Menzies R; McIntyre P
    Vaccine; 2014 Apr; 32(19):2204-8. PubMed ID: 24613527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D; Menschik D; Bryant-Genevier M; Ball R
    Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(31):989-92. PubMed ID: 20703207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card.
    de Lusignan S; Ferreira F; Damaso S; Byford R; Pathirannehelage S; Yeakey A; Yonova I; Schuind A; Dos Santos G
    Hum Vaccin Immunother; 2019; 15(5):1048-1059. PubMed ID: 30648923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ; Crawford N; Russell MA; Buttery JP
    Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010.
    Kelly H; Carcione D; Dowse G; Effler P
    Euro Surveill; 2010 Sep; 15(37):. PubMed ID: 20929647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
    Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
    JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms.
    Blyth CC; Currie AJ; Wiertsema SP; Conway N; Kirkham LA; Fuery A; Mascaro F; Geelhoed GC; Richmond PC
    Vaccine; 2011 Jul; 29(32):5107-13. PubMed ID: 21640152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ensuring safety of the 2011 trivalent influenza vaccine in young children.
    Blyth CC; Markus TY; Effler PV; Richmond PC
    Med J Aust; 2011 Jul; 195(1):52. PubMed ID: 21728948
    [No Abstract]   [Full Text] [Related]  

  • 17. Annual report: surveillance of adverse events following immunisation in Australia, 2010.
    Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network.
    Bettinger JA; De Serres G; Valiquette L; Vanderkooi OG; Kellner JD; Coleman BL; Top KA; Isenor JE; McCarthy AE;
    Euro Surveill; 2020 Jun; 25(22):. PubMed ID: 32524947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.
    Leeb A; Carcione D; Richmond PC; Jacoby P; Effler PV
    Vaccine; 2011 Oct; 29(45):7920-4. PubMed ID: 21864621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.